TABLE 4.
Other factors involved in hemostasis.
| Men [mean ± SD median (IQR)] | Women [mean ± SD median (IQR)] | Sex difference | Study | |
| MMP2 (ng/mL) | 0h: 752.5 ± 210.9 12h: 668.8 ± 254.6 24h: 599.0 ± 195.4 48h: 580.1 ± 188.0 mean: 644.2 ± 185.8 |
NS | Montaner et al., 2001 | |
| MMP9 (ng/mL) | 0h: 147.1 ± 118.6 12h: 140.4 ± 120.7 24h: 172.6 ± 139.0 48h: 144.5 ± 127.6 mean: 149.6 ± 99.0 |
NS | Montaner et al., 2001 | |
| MMP9 (ng/mL) | <24h: 668.9 (415.0–1022.0) | NS | Zhong et al., 2019 | |
| MMP9 (ng/mL) | 24h: 998.8 ± 154.7 1m: 800.3 ± 156.4 |
NS | Abdelnaseer et al., 2017 | |
| TIMP-1 (ng/mL) | <24h: 198.6 (163.7–241.2) | NS | Zhong et al., 2019 | |
| IGF-1 (ng/mL) | <24h: 129 (109–153) | NS | Dong et al., 2014 | |
| IGF-1 (ng/mL) | <24h: 112 (92–142) | NS | Zhang et al., 2018 | |
| Antiphosphatidyl serine (% positive) | <5d: 12.0 | <5d: 18.7 | NS | Tuhrim et al., 1999 |